Scandinavian ChemoTech

Scandinavian ChemoTech is a Swedish publicly traded life science and medical technology company developing and commercializing tumour-treatment systems based on its patented TSE (Tumour Specific Electroporation) platform. The company markets two main product lines: IQwave for human oncology and vetIQure for veterinary oncology, both designed to enhance local uptake of low-dose chemotherapy through dynamic electroporation while limiting damage to healthy tissue. ChemoTech focuses on superficial and accessible tumours in both human and animal health, with commercial activity in selected international markets and ongoing clinical validation efforts. The company positions its technology as a less destructive alternative to older electroporation and ablative approaches, and it operates through a small group structure spanning Sweden, Singapore, India, and the United States.